Panzenböck U, Kritharides L, Raftery M, Rye K A, Stocker R
Biochemistry and Clinical Research Groups, The Heart Research Institute, Camperdown, Sydney, New South Wales 2050, Australia.
J Biol Chem. 2000 Jun 30;275(26):19536-44. doi: 10.1074/jbc.M000458200.
The initial stage of oxidation of high density lipoproteins (HDL) is accompanied by the lipid hydroperoxide-dependent, selective oxidation of two of the three Met residues of apolipoprotein A-I (apoA-I) to Met sulfoxides (Met(O)). Formation of such selectively oxidized apoA-I (i.e. apoA-I(+32)) may affect the antiatherogenic properties of HDL, because it has been suggested that Met(86) and Met(112) are important for cholesterol efflux and Met(148) is involved in the activation of lecithin:cholesterol acyl transferase (LCAT). We therefore determined which Met residues were oxidized in apoA-I(+32) and how such oxidation of apoA-I affects its secondary structure, the affinity for lipids, and its ability to remove lipids from human macrophages. We also assessed the capacity of discoidal reconstituted HDL containing apoA-I(+32) to act as substrate for LCAT, and the dissociation of apoA-I and apoA-I(+32) from reconstituted HDL. Met(86) and Met(112) were present as Met(O), as determined by amino acid sequencing and mass spectrometry of isolated peptides derived from apoA-I(+32). Selective oxidation did not alter the alpha-helicity of lipid-free and lipid-associated apoA-I as assessed by circular dichroism, and the affinity for LCAT was comparable for reconstituted HDL containing apoA-I or apoA-I(+32). Cholesteryl ester transfer protein mediated the dissociation of apoA-I more readily from reconstituted HDL containing apoA-I(+32) than unoxidized apoA-I. Also, compared with native apoA-I, apoA-I(+32) had a 2- to 3-fold greater affinity for lipid (as determined by the rate of clearance of multilamellar phospholipid vesicles) and its ability to cause efflux of [(3)H]cholesterol, [(3)H]phospholipid, and [(14)C]alpha-tocopherol from lipid-laden human monocyte-derived macrophages was significantly enhanced. By contrast, no difference was observed for cholesterol and alpha-tocopherol efflux to lipid-associated apolipoproteins. Together, these results suggest that selective oxidation of Met residues enhances rather than diminishes known antiatherogenic activities of apoA-I, consistent with the overall hypothesis that detoxification of lipid hydroperoxides by HDL is potentially antiatherogenic.
高密度脂蛋白(HDL)氧化的初始阶段伴随着脂质过氧化氢依赖性、载脂蛋白A-I(apoA-I)三个甲硫氨酸(Met)残基中的两个被选择性氧化为甲硫氨酸亚砜(Met(O))。这种选择性氧化的apoA-I(即apoA-I(+32))的形成可能会影响HDL的抗动脉粥样硬化特性,因为有研究表明Met(86)和Met(112)对胆固醇流出很重要,而Met(148)参与卵磷脂:胆固醇酰基转移酶(LCAT)的激活。因此,我们确定了apoA-I(+32)中哪些Met残基被氧化,以及apoA-I的这种氧化如何影响其二级结构、对脂质的亲和力以及从人巨噬细胞中去除脂质的能力。我们还评估了含有apoA-I(+32)的盘状重组HDL作为LCAT底物的能力,以及apoA-I和apoA-I(+32)从重组HDL中的解离情况。通过对源自apoA-I(+32)的分离肽进行氨基酸测序和质谱分析,确定Met(86)和Met(112)以Met(O)的形式存在。通过圆二色性评估,选择性氧化并未改变无脂质和与脂质结合的apoA-I的α-螺旋度,并且含有apoA-I或apoA-I(+32)的重组HDL对LCAT的亲和力相当。胆固醇酯转运蛋白介导apoA-I从含有apoA-I(+32)的重组HDL中解离比未氧化的apoA-I更容易。此外,与天然apoA-I相比,apoA-I(+32)对脂质的亲和力高2至3倍(通过多层磷脂囊泡的清除率确定),并且其导致[³H]胆固醇、[³H]磷脂和[¹⁴C]α-生育酚从富含脂质的人单核细胞衍生巨噬细胞中流出的能力显著增强。相比之下,向与脂质结合的载脂蛋白中胆固醇和α-生育酚的流出未观察到差异。总之,这些结果表明Met残基的选择性氧化增强而非减弱了apoA-I已知的抗动脉粥样硬化活性,这与HDL对脂质过氧化氢解毒具有潜在抗动脉粥样硬化作用的总体假设一致。